Not investment advice. Educational platform. See Disclaimer.
NYSE: TMO
Thermo Fisher Scientific Inc.
Healthcare | Medical - Diagnostics & Research
$618.43as of 2026-09-04 11:21 UTC
Market Cap$233.8B
Volume1.80M
EPS (TTM)$17.74
Thermo Fisher Scientific Inc. (NYSE: TMO) is a $233.8B medical - diagnostics & research company trading at $618.43 — 34.9× trailing earnings, yielding 0.27%. Figures from SEC EDGAR and market feeds; updated 2026-09-04 11:21 UTC.
52-Week Range
Low $435.27High $647.00
What Thermo Fisher Scientific Inc. does
Thermo Fisher Scientific sells products and services to pharmaceutical companies, biotechnology firms, laboratories, universities, healthcare providers, government agencies, and research institutions. The company operates globally, with international markets contributing a substantial portion of revenues, and faces risks from economic downturns, inflation, currency fluctuations, tariffs, and geopolitical instability in the regions where it does business.
Summarized from Thermo Fisher Scientific Inc.’s SEC filings · Read the filing ↗
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Net income for FY2021, FY2022, FY2023, FY2024 is the filer’s available-to-common figure (net of preferred dividends) — the filer tags no parent net income for those years.
2026-01-12Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Thermo Fisher Scientific sells products and services to pharmaceutical companies, biotechnology firms, laboratories, universities, healthcare providers, government agencies, and research institutions.
What is TMO's valuation?
TMO trades at $618.43, 34.86× trailing earnings, 29.50× EV/EBITDA, as of 2026-09-04. It carries a 0.27% dividend yield.
When did TMO last file with the SEC?
Thermo Fisher Scientific Inc.'s most recent SEC filing on record is a 10-Q filed 2026-07-31. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 11:21 UTC. This page is also available as JSON at /api/data?ticker=TMO and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for TMO and 5,000+ tickers.
